287 related articles for article (PubMed ID: 15623821)
41. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake.
Tuncel M; Aydin D; Yaman E; Tazebay UH; Güç D; Doğan AL; Taşbasan B; Uğur O
Cancer Biother Radiopharm; 2007 Apr; 22(2):281-8. PubMed ID: 17600477
[TBL] [Abstract][Full Text] [Related]
42. Laminin receptors in differentiated thyroid tumors: restricted expression of the 67-kilodalton laminin receptor in follicular carcinoma cells.
Montuori N; Müller F; De Riu S; Fenzi G; Sobel ME; Rossi G; Vitale M
J Clin Endocrinol Metab; 1999 Jun; 84(6):2086-92. PubMed ID: 10372715
[TBL] [Abstract][Full Text] [Related]
43. Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines.
Schreck R; Schnieders F; Schmutzler C; Köhrle J
J Clin Endocrinol Metab; 1994 Sep; 79(3):791-8. PubMed ID: 8077363
[TBL] [Abstract][Full Text] [Related]
44. Modulation by retinoids of mRNA levels for nuclear retinoic acid receptors in murine melanoma cells.
Clifford JL; Petkovich M; Chambon P; Lotan R
Mol Endocrinol; 1990 Oct; 4(10):1546-55. PubMed ID: 2178220
[TBL] [Abstract][Full Text] [Related]
45. Differential effects of retinoic acid on growth and apoptosis in human colon cancer cell lines associated with the induction of retinoic acid receptor beta.
Lee MO; Han SY; Jiang S; Park JH; Kim SJ
Biochem Pharmacol; 2000 Mar; 59(5):485-96. PubMed ID: 10660115
[TBL] [Abstract][Full Text] [Related]
46. Loss of retinoic acid receptor beta gene expression is linked to aberrant histone H3 acetylation in lung cancer cell lines.
Suh YA; Lee HY; Virmani A; Wong J; Mann KK; Miller WH; Gazdar A; Kurie JM
Cancer Res; 2002 Jul; 62(14):3945-9. PubMed ID: 12124324
[TBL] [Abstract][Full Text] [Related]
47. Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells.
Xu J; Moatamed F; Caldwell JS; Walker JR; Kraiem Z; Taki K; Brent GA; Hershman JM
J Clin Endocrinol Metab; 2003 Oct; 88(10):4990-6. PubMed ID: 14557485
[TBL] [Abstract][Full Text] [Related]
48. RAR beta 2-mediated growth inhibition in HeLa cells.
Si SP; Lee X; Tsou HC; Buchsbaum R; Tibaduiza E; Peacocke M
Exp Cell Res; 1996 Feb; 223(1):102-11. PubMed ID: 8635481
[TBL] [Abstract][Full Text] [Related]
49. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
Rousseau C; Nichol JN; Pettersson F; Couture MC; Miller WH
Mol Cancer Res; 2004 Sep; 2(9):523-31. PubMed ID: 15383631
[TBL] [Abstract][Full Text] [Related]
50. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
[TBL] [Abstract][Full Text] [Related]
51. Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells.
Zhao Z; Zhang ZP; Soprano DR; Soprano KJ
Exp Cell Res; 1995 Aug; 219(2):555-61. PubMed ID: 7641808
[TBL] [Abstract][Full Text] [Related]
52. Regulation of retinoic acid receptor alpha expression in human neuroblastoma cell lines and tumor tissue.
Marshall GM; Cheung B; Stacey KP; Norris MD; Haber M
Anticancer Res; 1994; 14(2A):437-41. PubMed ID: 8017844
[TBL] [Abstract][Full Text] [Related]
53. Resveratrol Suppresses the Growth and Enhances Retinoic Acid Sensitivity of Anaplastic Thyroid Cancer Cells.
Li YT; Tian XT; Wu ML; Zheng X; Kong QY; Cheng XX; Zhu GW; Liu J; Li H
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29596381
[TBL] [Abstract][Full Text] [Related]
54. Retinoic Acid Receptor β: A Potential Therapeutic Target in Retinoic Acid Treatment of Endometrial Cancer.
Tsuji K; Utsunomiya H; Miki Y; Hanihara M; Fue M; Takagi K; Nishimoto M; Suzuki F; Yaegashi N; Suzuki T; Ito K
Int J Gynecol Cancer; 2017 May; 27(4):643-650. PubMed ID: 28375930
[TBL] [Abstract][Full Text] [Related]
55. Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells.
Kebebew E; Peng M; Treseler PA; Clark OH; Duh QY; Ginzinger D; Miner R
J Clin Endocrinol Metab; 2004 Dec; 89(12):6105-11. PubMed ID: 15579766
[TBL] [Abstract][Full Text] [Related]
56. Retinoic acid redifferentiation therapy for thyroid cancer.
Schmutzler C; Köhrle J
Thyroid; 2000 May; 10(5):393-406. PubMed ID: 10884186
[TBL] [Abstract][Full Text] [Related]
57. Effect of ligands of nuclear hormone receptors on sodium/iodide symporter expression and activity in breast cancer cells.
Tanosaki S; Ikezoe T; Heaney A; Said JW; Dan K; Akashi M; Koeffler HP
Breast Cancer Res Treat; 2003 Jun; 79(3):335-45. PubMed ID: 12846418
[TBL] [Abstract][Full Text] [Related]
58. Relationship between retinoic acid receptor alpha gene expression and growth-inhibitory effect of all-trans retinoic acid on canine tumor cells.
Miyajima N; Watanabe M; Ohashi E; Mochizuki M; Nishimura R; Ogawa H; Sugano S; Sasaki N
J Vet Intern Med; 2006; 20(2):348-54. PubMed ID: 16594593
[TBL] [Abstract][Full Text] [Related]
59. Response of cell growth and retinoic acid receptor expression to retinoic acid in neoplastic and non-neoplastic prostate cell lines.
Jones HE; Eaton CL; Barrow D; Dutkowski C; Griffiths K
Prostate; 1997 Feb; 30(3):174-82. PubMed ID: 9122042
[TBL] [Abstract][Full Text] [Related]
60. Adenovirus-mediated tumor suppressor p53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo.
Nagayama Y; Yokoi H; Takeda K; Hasegawa M; Nishihara E; Namba H; Yamashita S; Niwa M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4081-6. PubMed ID: 11095436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
